In 2021, semaglutides weight-loss brand Wegovy (weekly injectable) was approved for obesity, followed by tirzepatide (Mounjaro) for diabetes (2022) and Zepbound (tirzepatide for obesity) in late 2023
The judge, who presided over a four-week, non-jury trial conducted over Zoom, ordered Bristol-Myers and Sanofi to pay US$ 417 million each in penalties
Should the court rule in our favor, it is likely an award amount will be assigned to you based on the extent of the damages you sustained
The key is to listen to your body, communicate with your doctor, and dont ignore anything unusual
Glucagon-like peptide-1 (GLP-1) receptor agonist decreases blood glucose by promoting energy storage in adipose tissue and inhibiting glucagon secretion
Every batch of Tirz sold by Loti Labs undergoes third party testing using validated HPLC protocols